Clinical Trials Directory

Trials / Unknown

UnknownNCT04772066

Tools to Assess Medication Adherence

Evaluation of Tools to Assess Medication Adherence

Status
Unknown
Phase
Study type
Observational
Enrollment
600 (estimated)
Sponsor
University Hospital, Montpellier · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

The issue of medication adherence (MA) has long been undestimated but is now growing interest due to both the increase of patients with chronic diseases and the aging of the population. According to the World Health Organization, only 50% of patients with chronic illnesses correctly follow physician's prescriptions in developed countries. Beyond the individual consequences that failure to adherence can engender (increased morbidity, mortality and hospitalizations), this concept also encompasses a collective dimension (risk of transmission of infectious diseases and increased health care costs). Today, improving MA would have more impact on human health than developping new medical therapies. That's why detecting non-adherence constitutes a major public health issue in which pharmacists play a significant role through medication reconciliation and patients' education. The methods wildly used are based on indirect measurement: questionnaires completed by the patient himself or the Medication Possession Ratio (MPR). Each method has its own advantages and disadvantages, but none is considered as the gold standard. The Montpellier University Hospital set up a MA self-report scale ranging from 0 (low) to 10 (high adherence) in the various care units where the clinical pharmacy activity is deployed. The purpose of this study was to assess the MA according to this numerical scale and the MPR calculation, and evaluate the correlation between these two methods.

Conditions

Interventions

TypeNameDescription
OTHERMeasure of medication adherenceMeasure of medication adherence

Timeline

Start date
2019-11-01
Primary completion
2021-12-01
Completion
2021-12-30
First posted
2021-02-26
Last updated
2021-03-08

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04772066. Inclusion in this directory is not an endorsement.